https://www.selleckchem.com/pr....oducts/Pomalidomide(
to detect disease progression in the territory of the contralateral carotid artery and PCA and prevent late cerebrovascular events.OBJECTIVE Given the paucity of data on the natural history of brainstem cavernous malformations (CMs), the authors aimed to evaluate the annual hemorrhage rate and hemorrhagic risk of brainstem CMs. METHODS Nine hundred seventy-nine patients diagnosed with brainstem CMs were referred to Beijing Tiantan Hospital from 2006 to 2015; 224 patients were excluded according to exclusion criteria, and 4